Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B-lymphocyte Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. An Open Label Phase II Study With Rituximab Induction and Maintenance Treatment

NCT01156909 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT01156909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01156909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B-lymphocyte Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. An Open Label Phase II Study With Rituximab Induction and Maintenance Treatment
Lead sponsor
Haukeland University Hospital
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2010
Completion date
February 28, 2014
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue syndrome, myalgic encephalomyelitis